Cargando…

VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses

BACKGROUND: Selection of effective viral siRNA is an indispensable step in the development of siRNA based antiviral therapeutics. Despite immense potential, a viral siRNA efficacy prediction algorithm is still not available. Moreover, performances of the existing general mammalian siRNA efficacy pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Abid, Thakur, Nishant, Kumar, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878835/
https://www.ncbi.nlm.nih.gov/pubmed/24330765
http://dx.doi.org/10.1186/1479-5876-11-305
_version_ 1782297874865848320
author Qureshi, Abid
Thakur, Nishant
Kumar, Manoj
author_facet Qureshi, Abid
Thakur, Nishant
Kumar, Manoj
author_sort Qureshi, Abid
collection PubMed
description BACKGROUND: Selection of effective viral siRNA is an indispensable step in the development of siRNA based antiviral therapeutics. Despite immense potential, a viral siRNA efficacy prediction algorithm is still not available. Moreover, performances of the existing general mammalian siRNA efficacy predictors are not satisfactory for viral siRNAs. Therefore, we have developed “VIRsiRNApred” a support vector machine (SVM) based method for predicting the efficacy of viral siRNA. METHODS: In the present study, we have employed a new dataset of 1725 viral siRNAs with experimentally verified quantitative efficacies tested under heterogeneous experimental conditions and targeting as many as 37 important human viruses including HIV, Influenza, HCV, HBV, SARS etc. These siRNAs were divided into training (T(1380)) and validation (V(345)) datasets. Important siRNA sequence features including mono to penta nucleotide frequencies, binary pattern, thermodynamic properties and secondary structure were employed for model development. RESULTS: During 10-fold cross validation on T(1380) using hybrid approach, we achieved a maximum Pearson Correlation Coefficient (PCC) of 0.55 between predicted and actual efficacy of viral siRNAs. On V(345) independent dataset, our best model achieved a maximum correlation of 0.50 while existing general siRNA prediction methods showed PCC from 0.05 to 0.18. However, using leave one out cross validation PCC was improved to 0.58 and 0.55 on training and validation datasets respectively. SVM performed better than other machine learning techniques used like ANN, KNN and REP Tree. CONCLUSION: VIRsiRNApred is the first algorithm for predicting inhibition efficacy of viral siRNAs which is developed using experimentally verified viral siRNAs. We hope this algorithm would be useful in predicting highly potent viral siRNA to aid siRNA based antiviral therapeutics development. The web server is freely available at http://crdd.osdd.net/servers/virsirnapred/.
format Online
Article
Text
id pubmed-3878835
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38788352014-01-07 VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses Qureshi, Abid Thakur, Nishant Kumar, Manoj J Transl Med Research BACKGROUND: Selection of effective viral siRNA is an indispensable step in the development of siRNA based antiviral therapeutics. Despite immense potential, a viral siRNA efficacy prediction algorithm is still not available. Moreover, performances of the existing general mammalian siRNA efficacy predictors are not satisfactory for viral siRNAs. Therefore, we have developed “VIRsiRNApred” a support vector machine (SVM) based method for predicting the efficacy of viral siRNA. METHODS: In the present study, we have employed a new dataset of 1725 viral siRNAs with experimentally verified quantitative efficacies tested under heterogeneous experimental conditions and targeting as many as 37 important human viruses including HIV, Influenza, HCV, HBV, SARS etc. These siRNAs were divided into training (T(1380)) and validation (V(345)) datasets. Important siRNA sequence features including mono to penta nucleotide frequencies, binary pattern, thermodynamic properties and secondary structure were employed for model development. RESULTS: During 10-fold cross validation on T(1380) using hybrid approach, we achieved a maximum Pearson Correlation Coefficient (PCC) of 0.55 between predicted and actual efficacy of viral siRNAs. On V(345) independent dataset, our best model achieved a maximum correlation of 0.50 while existing general siRNA prediction methods showed PCC from 0.05 to 0.18. However, using leave one out cross validation PCC was improved to 0.58 and 0.55 on training and validation datasets respectively. SVM performed better than other machine learning techniques used like ANN, KNN and REP Tree. CONCLUSION: VIRsiRNApred is the first algorithm for predicting inhibition efficacy of viral siRNAs which is developed using experimentally verified viral siRNAs. We hope this algorithm would be useful in predicting highly potent viral siRNA to aid siRNA based antiviral therapeutics development. The web server is freely available at http://crdd.osdd.net/servers/virsirnapred/. BioMed Central 2013-12-11 /pmc/articles/PMC3878835/ /pubmed/24330765 http://dx.doi.org/10.1186/1479-5876-11-305 Text en Copyright © 2013 Qureshi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Qureshi, Abid
Thakur, Nishant
Kumar, Manoj
VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title_full VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title_fullStr VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title_full_unstemmed VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title_short VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses
title_sort virsirnapred: a web server for predicting inhibition efficacy of sirnas targeting human viruses
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878835/
https://www.ncbi.nlm.nih.gov/pubmed/24330765
http://dx.doi.org/10.1186/1479-5876-11-305
work_keys_str_mv AT qureshiabid virsirnapredawebserverforpredictinginhibitionefficacyofsirnastargetinghumanviruses
AT thakurnishant virsirnapredawebserverforpredictinginhibitionefficacyofsirnastargetinghumanviruses
AT kumarmanoj virsirnapredawebserverforpredictinginhibitionefficacyofsirnastargetinghumanviruses